LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 206 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.46 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $311 | -16.8% | 5,190 | 0.0% | 0.00% | -25.0% |
Q2 2023 | $374 | +3.6% | 5,190 | +5.7% | 0.00% | 0.0% |
Q1 2023 | $361 | +10.1% | 4,909 | 0.0% | 0.00% | +33.3% |
Q4 2022 | $328 | -99.9% | 4,909 | -10.6% | 0.00% | -50.0% |
Q3 2022 | $473,000 | -19.1% | 5,489 | +5.6% | 0.01% | 0.0% |
Q1 2022 | $585,000 | -27.1% | 5,200 | 0.0% | 0.01% | -14.3% |
Q4 2021 | $803,000 | +43.4% | 5,200 | +29.3% | 0.01% | +40.0% |
Q3 2021 | $560,000 | +180.0% | 4,021 | +164.4% | 0.01% | +150.0% |
Q2 2021 | $200,000 | -13.8% | 1,521 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $232,000 | +53.6% | 1,521 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $151,000 | -41.7% | 1,521 | -44.1% | 0.00% | -33.3% |
Q3 2020 | $259,000 | -26.4% | 2,722 | -13.6% | 0.00% | -25.0% |
Q2 2020 | $352,000 | +53.7% | 3,150 | 0.0% | 0.00% | +33.3% |
Q1 2020 | $229,000 | -43.7% | 3,150 | -19.2% | 0.00% | -25.0% |
Q4 2019 | $407,000 | +4.9% | 3,900 | 0.0% | 0.00% | -20.0% |
Q3 2019 | $388,000 | -17.8% | 3,900 | -5.8% | 0.01% | -16.7% |
Q2 2019 | $472,000 | -34.5% | 4,140 | -27.9% | 0.01% | -33.3% |
Q1 2019 | $721,000 | -13.4% | 5,740 | -6.5% | 0.01% | -18.2% |
Q4 2018 | $833,000 | -52.9% | 6,140 | -4.7% | 0.01% | -47.6% |
Q3 2018 | $1,768,000 | +28.5% | 6,440 | -3.0% | 0.02% | +31.2% |
Q2 2018 | $1,376,000 | +25.4% | 6,640 | 0.0% | 0.02% | +23.1% |
Q1 2018 | $1,097,000 | +35.8% | 6,640 | +12.5% | 0.01% | +44.4% |
Q4 2017 | $808,000 | +0.6% | 5,900 | 0.0% | 0.01% | -10.0% |
Q3 2017 | $803,000 | +12.2% | 5,900 | 0.0% | 0.01% | +11.1% |
Q2 2017 | $716,000 | +7.3% | 5,900 | -6.3% | 0.01% | +12.5% |
Q1 2017 | $667,000 | -6.2% | 6,300 | -10.0% | 0.01% | -11.1% |
Q4 2016 | $711,000 | -5.8% | 7,000 | -5.4% | 0.01% | -10.0% |
Q3 2016 | $755,000 | -14.5% | 7,400 | 0.0% | 0.01% | -16.7% |
Q2 2016 | $883,000 | +11.5% | 7,400 | 0.0% | 0.01% | +20.0% |
Q1 2016 | $792,000 | +4.3% | 7,400 | +5.7% | 0.01% | 0.0% |
Q4 2015 | $759,000 | +45.4% | 7,000 | +14.8% | 0.01% | +42.9% |
Q3 2015 | $522,000 | -15.1% | 6,100 | 0.0% | 0.01% | 0.0% |
Q2 2015 | $615,000 | +30.9% | 6,100 | 0.0% | 0.01% | +40.0% |
Q1 2015 | $470,000 | +44.6% | 6,100 | 0.0% | 0.01% | +25.0% |
Q4 2014 | $325,000 | +13.2% | 6,100 | 0.0% | 0.00% | +33.3% |
Q3 2014 | $287,000 | -24.5% | 6,100 | 0.0% | 0.00% | -25.0% |
Q2 2014 | $380,000 | -15.7% | 6,100 | -9.0% | 0.00% | -20.0% |
Q1 2014 | $451,000 | +28.1% | 6,700 | 0.0% | 0.01% | +25.0% |
Q4 2013 | $352,000 | – | 6,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |